Menu shortcut Contents shortcut

PRODUCTS

homePRODUCTS > Medicine > Injection

Hyaluronidase Liquified Hirax inj.

About Hyaluronidase Hyaluronidase is an enzyme hydrolyzing the substance in between the cells of connective tissues. It regulates the connectivity of intercellular space to facilitate easy absorption and diffusion of medications.
The use of hyaluronidase has recently been greatly expanded based on such features. In particular, it is used as a topical anesthetic supplement, as well as a reducing agent of chronic neuralgia by restricting the proliferation of fibrous tissues.
It is also used in preventing and treating swelling and bruise caused by surgical operations, and is effective in eliminating edema.

Liquified Hirax is a hyaluronidase drug of high purity, safety, and quality. The location of edema is where the internal immune system is actively acting, so a high-purity hyaluronidase should be used, instead of low-purity hyaluronidase that includes foreign proteins.

Occurrence and Treatment of Edema

Occurrence and Treatment of Edema
Product name Hirax inj.
Ingredient and Content Amount Hyaluronidase 2,000 I.U. / 1ml, Hyaluronidase 1,500 I.U. / 1ml, Hyaluronidase 750 I.U. / 0.5ml
Description Vial injection drug filled with colorless transparent liquid
Efficacy and Effects Increases the penetration in cases of hypodermic injection, intramuscular injection, topical anesthetic, and subcutaneous transfusion
Promotes reabsorption of bodily fluids and blood that are excessively present in the tissues
Method of Use 1. Subcutaneous Transfusion (Large Amount Hypodermic Injection)
Before performing subcutaneous transfusion, inject 1,500 I.U. (1mL) of hyaluronidase, or inject it into the tube about 2cm above the injection needle when beginning the injection. About 1,500 I.U. of this drug is adequate when injecting 500~1,000 mL of intravenous. A careful control of injection speed and amount is required for children or senior people.
Pay particular attention not to cause overhydration when the patient has kidney problems. 2. Hypodermic Injection and Intramuscular Injection
Directly mix about 1,500 I.U. of this drug with the injection liquid before use.
3. Local Anesthesia
Mix about 1,500 I.U. of this drug with the injection liquid before use.
About 15 I.U. per mL is recommended for ophthalmic use.
4. Extravasation
When diffusion, instead of local phenomenon is observed, permeate about 1,500 I.U. (1mL) of this drug to the lesion as quickly as possible after extravasation has occurred.
5. A topical anesthetic
Permeate about 1,500 I.U. (1mL) of this drug to the area.
Hypodermic injection drug should be isotonic with the extracellular fluid. This drug can be mixed with generally used transfusion agents. For the large amount hypodermic injection, cases were reported that this drug was used in mixture with physiological saline, 0.18% sodium chloride, 4% glucose, 0.45% sodium chloride, 2.5% glucose, 5% glucose.
Potassium is injected as 34 mmol/L in the mixture of isotonic glucose or physiological saline.
The transfusion agents containing electrolytes are more appropriate than the agents not containing electrolytes, and the speed of injection should not be too fast. The use of this drug is done in the mixture with morphine, diamorphine, hydromorphine, chlorpromazine, metoclopramide, promazine, dexamethasone, topical anesthetic, or epinephrine.
Packing unit 10vials/box
상단으로